FDA to 'institutionalize' compounding regulation to 'protect consumers'

In-PharmaTechnologist.com-Jun 19, 2019

The US FDA is set to center its drug compounding regulatory program in an office focused on stopping poor quality, unsafe and ineffective drugs reaching